KSI-3716 |
カタログ番号GC33377 |
KSI-3716 は、標的遺伝子プロモーターへの c-MYC/MAX 結合をブロックする強力な c-Myc 阻害剤です。 KSI-3716 は、膀胱癌に対する有効な膀胱内化学療法剤です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1151813-61-4
Sample solution is provided at 25 µL, 10mM.
KSI-3716 is a c-Myc inhibitor.
KSI-3716 blocks c-MYC/MAX from forming a complex with target gene promoters. KSI-3716 effectively blocks complex formation in a dose dependent manner (IC50=0.84 μM). c-MYC mediated transcriptional activity is inhibited by KSI-3716 at concentrations as low as 1 μM. The expression of c-MYC target genes, such as cyclin D2, CDK4 and hTERT, is markedly decreased. KSI-3716 exerts cytotoxic effects on bladder cancer cells by inducing cell cycle arrest and apoptosis[1].
Intravesical instillation of KSI-3716 at a dose of 5 mg/kg significantly suppresses tumor growth with minimal systemic toxicity[1].
[1]. Jeong KC, et al. Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth. J Urol. 2014 Feb;191(2):510-8.
Average Rating: 5
(Based on Reviews and 13 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *